Sartorius Aktiengesellschaft (SUVPF)
USD 224.0
(0.0%)
USD 224.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.03 Billion EUR | -12.07% |
| 2022 | 1.17 Billion EUR | 34.9% |
| 2021 | 874.07 Million EUR | 58.43% |
| 2020 | 551.71 Million EUR | 35.07% |
| 2019 | 408.47 Million EUR | 28.33% |
| 2018 | 318.28 Million EUR | 31.71% |
| 2017 | 241.65 Million EUR | 11.1% |
| 2016 | 217.52 Million EUR | 16.77% |
| 2015 | 186.27 Million EUR | 29.3% |
| 2014 | 144.06 Million EUR | 7.23% |
| 2013 | 134.34 Million EUR | 10.76% |
| 2012 | 121.29 Million EUR | 17.99% |
| 2011 | 102.8 Million EUR | 33.94% |
| 2010 | 76.75 Million EUR | 10.28% |
| 2009 | 69.6 Million EUR | -27.21% |
| 2008 | 95.61 Million EUR | 11.57% |
| 2007 | 85.7 Million EUR | 21.17% |
| 2006 | 70.73 Million EUR | 1.59% |
| 2005 | 69.62 Million EUR | 0.78% |
| 2004 | 69.08 Million EUR | 2.37% |
| 2003 | 67.48 Million EUR | -3.72% |
| 2002 | 70.09 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.02 Billion EUR | -0.88% |
| 2024 Q3 | 868 Million EUR | -7.22% |
| 2024 Q2 | 935.5 Million EUR | -8.97% |
| 2023 Q2 | 1.19 Billion EUR | -1.92% |
| 2023 Q4 | 1.03 Billion EUR | -10.19% |
| 2023 Q3 | 1.15 Billion EUR | -3.27% |
| 2023 FY | 1.03 Billion EUR | -12.07% |
| 2023 Q1 | 1.21 Billion EUR | 3.19% |
| 2022 Q3 | 1.21 Billion EUR | 10.94% |
| 2022 Q2 | 1.09 Billion EUR | 11.85% |
| 2022 Q4 | 1.17 Billion EUR | -2.84% |
| 2022 Q1 | 978 Million EUR | 11.89% |
| 2022 FY | 1.17 Billion EUR | 34.9% |
| 2021 Q3 | 804.7 Million EUR | 16.5% |
| 2021 FY | 874.07 Million EUR | 58.43% |
| 2021 Q2 | 690.7 Million EUR | 10.8% |
| 2021 Q1 | 623.4 Million EUR | 12.99% |
| 2021 Q4 | 874.07 Million EUR | 8.62% |
| 2020 Q3 | 531.7 Million EUR | 5.54% |
| 2020 FY | 551.71 Million EUR | 35.07% |
| 2020 Q1 | 426.6 Million EUR | 4.44% |
| 2020 Q2 | 503.8 Million EUR | 18.1% |
| 2020 Q4 | 551.71 Million EUR | 3.76% |
| 2019 FY | 408.47 Million EUR | 28.33% |
| 2019 Q4 | 408.47 Million EUR | 1.56% |
| 2019 Q3 | 402.2 Million EUR | 8.76% |
| 2019 Q2 | 369.8 Million EUR | 6.39% |
| 2019 Q1 | 347.6 Million EUR | 9.21% |
| 2018 Q4 | 318.28 Million EUR | 2.61% |
| 2018 Q2 | 282.3 Million EUR | 5.81% |
| 2018 FY | 318.28 Million EUR | 31.71% |
| 2018 Q1 | 266.8 Million EUR | 10.4% |
| 2018 Q3 | 310.2 Million EUR | 9.88% |
| 2017 FY | 241.65 Million EUR | 11.1% |
| 2017 Q1 | 243.1 Million EUR | 11.76% |
| 2017 Q3 | 247.6 Million EUR | 2.36% |
| 2017 Q4 | 241.65 Million EUR | -2.4% |
| 2017 Q2 | 241.9 Million EUR | -0.49% |
| 2016 Q3 | 227.1 Million EUR | 2.99% |
| 2016 FY | 217.52 Million EUR | 16.77% |
| 2016 Q4 | 217.52 Million EUR | -4.22% |
| 2016 Q2 | 220.5 Million EUR | 6.42% |
| 2016 Q1 | 207.2 Million EUR | 11.23% |
| 2015 Q4 | 186.27 Million EUR | 2.41% |
| 2015 FY | 186.27 Million EUR | 29.3% |
| 2015 Q1 | 170.7 Million EUR | 18.49% |
| 2015 Q2 | 181.6 Million EUR | 6.39% |
| 2015 Q3 | 181.9 Million EUR | 0.17% |
| 2014 FY | 144.06 Million EUR | 7.23% |
| 2014 Q3 | 169.2 Million EUR | 8.6% |
| 2014 Q1 | 146.7 Million EUR | 9.19% |
| 2014 Q4 | 144.06 Million EUR | -14.86% |
| 2014 Q2 | 155.8 Million EUR | 6.2% |
| 2013 Q2 | 138.5 Million EUR | 0.65% |
| 2013 Q1 | 137.6 Million EUR | 13.44% |
| 2013 FY | 134.34 Million EUR | 10.76% |
| 2013 Q4 | 134.34 Million EUR | -5.85% |
| 2013 Q3 | 142.7 Million EUR | 3.03% |
| 2012 Q4 | 121.29 Million EUR | -5.24% |
| 2012 Q3 | 128 Million EUR | 6.4% |
| 2012 FY | 121.29 Million EUR | 17.99% |
| 2012 Q1 | 113.7 Million EUR | 10.6% |
| 2012 Q2 | 120.3 Million EUR | 5.8% |
| 2011 Q4 | 102.8 Million EUR | -0.58% |
| 2011 FY | 102.8 Million EUR | 33.94% |
| 2011 Q2 | 96.5 Million EUR | 6.75% |
| 2011 Q3 | 103.4 Million EUR | 7.15% |
| 2011 Q1 | 90.4 Million EUR | 17.77% |
| 2010 Q4 | 76.75 Million EUR | -6.05% |
| 2010 Q1 | 78 Million EUR | 12.06% |
| 2010 FY | 76.75 Million EUR | 10.28% |
| 2010 Q3 | 81.7 Million EUR | -2.51% |
| 2010 Q2 | 83.8 Million EUR | 7.44% |
| 2009 Q4 | 69.6 Million EUR | 0.0% |
| 2009 FY | 69.6 Million EUR | -27.21% |
| 2008 FY | 95.61 Million EUR | 11.57% |
| 2007 FY | 85.7 Million EUR | 21.17% |
| 2006 FY | 70.73 Million EUR | 1.59% |
| 2005 FY | 69.62 Million EUR | 0.78% |
| 2004 FY | 69.08 Million EUR | 2.37% |
| 2003 FY | 67.48 Million EUR | -3.72% |
| 2002 FY | 70.09 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -774619.978% |
| Ansell Limited | 457.04 Million USD | -126.85% |
| Ansell Limited | 457.9 Million USD | -126.425% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -2292.488% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -3717361.456% |
| Psykey, Inc. | 49.94 Thousand USD | -2075991.31% |
| ConvaTec Group Plc | 395.54 Million USD | -162.122% |
| ConvaTec Group Plc | 396.1 Million USD | -161.752% |
| Encision Inc. | 1.4 Million USD | -73833.674% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 11155684.248% |
| LifePoint, Inc. | 2.3 Million USD | -44795.886% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -43046.067% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -235002.041% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -1128303.822% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -106534.523% |
| SmileDirectClub, Inc. | 49.87 Million USD | -1978.839% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | -194.756% |
| SheerVision, Inc. | 339.66 Thousand USD | -305143.727% |
| United Health Products, Inc. | 33.59 Thousand USD | -3085797.97% |
| Vasamed, Inc. | 449.02 Thousand USD | -230798.741% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -12119128.521% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -321714.677% |